← All trials
NCT03145012
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 15, 2017
- Primary completion
- Apr 30, 2018
- Completion date
- Oct 31, 2018
- First posted
- —
- Last posted
- —
- Enrollment
- 30
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- Government of Nova ScotiaLead sponsor
- Dalhousie UniversityCollaborator
- Government of CanadaCollaborator
- Government of CanadaOverall official - principal investigator
- Government of CanadaSponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.